G100S (p.Gly100Ser) variant of MEFV (Pyrin)

G100S (p.Gly100Ser) in MEFV (Pyrin) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.16 / 1. The record also includes population frequency data and structural context.

G100S (p.Gly100Ser) variant details